BCL9 Blocking Peptide (N-Term)
€363.00
In stock
SKU
AC-BP21507a
Background:
Involved in signal transduction through the Wnt pathway. Promotes beta-catenin's transcriptional activity (By similarity).
Other Names:
B-cell CLL/lymphoma 9 protein, B-cell lymphoma 9 protein, Bcl-9, Protein legless homolog, BCL9
Target/Specificity:
The synthetic peptide sequence is selected from aa 272-284 of HUMAN BCL9
Gene Name: BCL9
Gene ID: 607
Primary Accession: O00512
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Involved in signal transduction through the Wnt pathway. Promotes beta-catenin's transcriptional activity (By similarity).
Other Names:
B-cell CLL/lymphoma 9 protein, B-cell lymphoma 9 protein, Bcl-9, Protein legless homolog, BCL9
Target/Specificity:
The synthetic peptide sequence is selected from aa 272-284 of HUMAN BCL9
Gene Name: BCL9
Gene ID: 607
Primary Accession: O00512
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review